生物材料全球市場規模、份額和增長分析（按類型、應用）- 2023-2030 年行業預測

Global Biomaterials Market Size, Share, Growth Analysis, By Type(Natural Biomaterial, Metallic Biomaterial), By Application(Neurology, Cardiology) - Industry Forecast 2023-2030

出版日期: 2023年04月29日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球生物材料市場規模預計將從 2022 年的 1559 億美元增至 2030 年的 4381 億美元，在預測期內（2023-2030 年）複合年增長率為 15.4%。人口老齡化和慢性疾病流行正在推動對生物材料的需求。

本報告研究和分析了全球生物材料市場，提供市場動態和前景、細分市場分析、公司簡介等。

內容

執行摘要

調查方法

母市場分析

主要市場考慮因素

技術分析
價格分析
供應鏈分析
價值鏈分析
市場生態系統
知識產權分析
貿易分析
啟動分析
原材料分析
創新矩陣
管道產品分析
宏觀經濟指標
主要投資分析
關鍵成功因素
爭用程度

市場動態與展望

市場動態
驅動程序
機會
制約因素
任務
監管情況
波特五力分析
對未來混亂的特殊考慮

全球生物材料市場：按類型

市場概況
天然生物材料
金屬生物材料
陶瓷生物材料
高分子生物材料

全球生物材料市場：按應用

市場概況
神經
心
骨科
眼科
傷口護理
牙科
整形外科
其他用途

全球生物材料市場規模：按地區

市場概況
北美
美國
加拿大
歐洲
德國
西班牙
法國
英國
歐洲其他地區
亞太地區
中國
印度
日本
韓國
亞太地區其他地區
拉丁美洲
巴西
其他拉丁美洲地區
中東和非洲
海灣合作委員會國家
南非
其他中東和非洲地區

競爭格局

前 5 家公司的比較
主要公司的市場定位（2021 年）
主要市場公司採用的策略
關鍵成功策略
最近的市場活動
主要公司的市場份額（2021 年）

主要公司簡介

Evonik Industries AG
Corbion
BASF SE
Royal DSM NV
Invibio Ltd.
Carpenter Technology Corporation
Celanese Corporation
Berkeley Advanced Biomaterials, Inc.
Cam Bioceramics B.V.
Collagen Matrix, Inc.
Bayer AG
Medtronic plc
Wright Medical Group N.V.
Zimmer Biomet Holdings, Inc.
Stryker Corporation
Danaher Corporation
Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
3M Company
DuPont de Nemours, Inc.

簡介目錄

Product Code: SQMIG35H2027

Biomaterials Market size was valued at USD 135.4 billion in 2021 and is poised to grow from USD 155.9 billion in 2022 to USD 438.1 billion by 2030, growing at a CAGR of 15.4% in the forecast period (2023-2030).

The global biomaterials market refers to the industry that involves the production and application of materials that are compatible with biological systems, such as human tissues and organs. Biomaterials play a crucial role in medical and healthcare applications, including implantable medical devices, tissue engineering, drug delivery systems, and regenerative medicine. These materials are designed to interact with biological systems without causing adverse reactions and promote healing and tissue regeneration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomaterials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global biomaterials market is segmented on the basis of type, application, and region. Based on the type, the market is segmented into natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. Based on the application, the market is segmented as neurology, cardiology, orthopedics, ophthalmology, wound care, dental, plastic surgery, and other applications. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The aging population and the increasing prevalence of chronic diseases drive the demand for biomaterials. Biomaterials are used in various medical procedures, such as joint replacements, cardiovascular implants, and dental applications, to enhance the quality of life for patients suffering from age-related conditions or chronic illnesses. Technological advancements in medical devices and procedures fuel the demand for biomaterials. The development of innovative biomaterials enables the design of more effective and biocompatible medical implants, prosthetics, and drug delivery systems, leading to improved patient outcomes and expanded treatment options.

Restraint

The development and production of biomaterials involve extensive research, rigorous testing, and compliance with regulatory standards. These processes can be expensive, leading to higher costs associated with biomaterials. The high cost can limit their widespread adoption, particularly in resource-constrained healthcare systems.

Market Trends

There is a growing emphasis on bioactive and biodegradable biomaterials that can interact with the body's tissues, promote healing, and gradually degrade over time. These materials reduce the need for additional surgeries for implant removal, enhance patient comfort, and support the regeneration of functional tissues. The integration of 3D printing and additive manufacturing technologies in the production of biomaterials offers new opportunities for customization and precision in medical applications. 3D printing allows for the fabrication of complex structures, patient-specific implants, and scaffold designs, revolutionizing the field of personalized medicine and tissue engineering.